How The U.S. Response To Ebola Shows Failures On Lessons From COVID-19

The U.S. Ebola response has been reactionary as opposed to proactive. A doctor breaks down why and how it mirrors the U.S.
CNN

Covid-19 vaccine policy changes raise questions and concerns for US adults as summer wave ramps up

As Covid-19 transmission ramps up in the United States, recent changes to federal vaccine guidance have left many Americans confused about the latest policies and concerned about access to shots this ...

This was the moment the COVID-19 experts betrayed us

Some tweets live in infamy. Six years ago this week, NPR shared a link on X (Twitter at the time) to an article by ...

First pill to prevent COVID-19 after exposure approved by FDA

The FDA has approved the first and only pill to prevent COVID-19 after exposure to the virus. Here's how it works. (Photo: ...
Time

COVID-19 Is Rising Again. Here's What to Know

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

US infant mortality uptick falsely linked to Covid-19 vaccination

The infant mortality rate in the United States rose for the first time in two decades between 2021 and 2022, but social media ...

Have COVID-19 vaccines contributed to as many as 3.9 million deaths?

No. COVID-19 vaccines have not been linked to as many as 3.9 million deaths. Wisconsin U.S. Sen. Ron Johnson said on May 9, ...
Medical Xpress

US COVID-19 school closures were not cost-effective, but other non-pharmaceutical interventions were, study finds

School closures during the COVID-19 pandemic imposed enormous long-term costs while other measures delivered better health outcomes for far less money, according to new research led by Oxford ...

Coronavirus in Vermont, northern New York and New Hampshire: What you need to know

The COVID-19 vaccine distribution process continues in Vermont and northern New York.
Politifact

What we know about the new COVID-19 variant ‘cicada’ or BA.3.2.

COVID-19 variant BA.3.2 or "cicada" is not widely circulating in the U.S. yet, but based on trends in Europe, it may become more prominent. Most evidence comes from laboratory data, but there are no ...